Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-23-016532

Director acquired 4,043 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DIXON WENDY L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-15 Grant or award : show line 1 in the form +4,043 $2.73 $11,037 34,801 D
Loading xslF345X05/form4-12152023_091215.xml…